Genetics

This blog post examines a Brain article investigating the role of polygenic risk scores in multiple sclerosis susceptibility and disease phenotype among European-ancestry cohorts. The study demonstrates that aggregated genetic risk can improve disease-risk stratification beyond conventional factors such as age, sex, smoking, infectious mononucleosis, family history, and body mass index. It also highlights biologically relevant immune, viral-response, inflammatory, and neurodegenerative pathways associated with multiple sclerosis risk. Beyond susceptibility prediction, the article connects genetic burden with familial risk patterns, relapse activity, and MRI-based evidence of thalamic atrophy, emphasizing the potential of polygenic profiling as a future tool for targeted screening, early monitoring, and precision medicine.